Exciting news. it’s almost like they have been on the HotCopper boards to see what share holders want. And we want news regarding progress of trials and results.
Still room on this rocket before it takes off.
I might have to look under the couch for some pennies.
I enjoyed reading the comparison table between the CBD oils and RX5.
Clearly demonstrates the companies beliefs in the product and the gap in the current market that this product fills.
bring on the next 12 months I say.
as always DYOR
Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $17.73M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $71.48K | 2.457M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 120800 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 1018286 | 4 |
View Market Depth
| Last trade - 15.42pm 15/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |